Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Highlighting Zero Based Budget success stories from single parents, these narratives showcase wins, lessons learned, and practical strategies.
23,980 articlesA major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Orion (OESX) 2026 earnings reveal a company navigating growth opportunities and profitability challenges. This deep d...
Axsome's 2025 earnings season is shaping up as a pivotal moment for investors. This article breaks down what to expec...
Meta posted solid earnings, yet the stock slipped. This guide breaks down why and how to decide if the pullback creat...
Lighter’s upgraded liquidity framework held firm during a $50 million ARC perpetual squeeze, enforcing a $75,000 cap ...
As SpaceX opens trading, savvy investors wonder how much upside the IPO price may still hold. This deep-dive walks th...
As quantum computing moves from pilots to real deployments, ionq stock revenue growth becomes a focal point for inves...
A new NVIDIA-backed player has stepped into the high-growth AI photonics space, challenging traditional data-center b...
Axos Financial has delivered a notable 12-month gain, with a recent fund trim adding a twist to the story. This artic...
Taylor Swift and Travis Kelce announced a $26 million donation to 20 charities this week, fueling talk of a Friday Ma...
Biotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
A free cash flow ETF is delivering a surprising edge in 2026, outperforming the S&P 500 as investors rotate toward ca...